Prosecution Insights
Last updated: April 19, 2026
Application No. 18/465,302

CATALYST STACKED BED SYSTEM WITH VARYING METAL CONCENTRATION FOR TRANSALKYLATION PROCESS

Non-Final OA §103
Filed
Sep 12, 2023
Examiner
COHEN, STEFANIE J
Art Unit
1732
Tech Center
1700 — Chemical & Materials Engineering
Assignee
UOP LLC
OA Round
1 (Non-Final)
75%
Grant Probability
Favorable
1-2
OA Rounds
2y 10m
To Grant
78%
With Interview

Examiner Intelligence

Grants 75% — above average
75%
Career Allow Rate
719 granted / 954 resolved
+10.4% vs TC avg
Minimal +3% lift
Without
With
+2.7%
Interview Lift
resolved cases with interview
Typical timeline
2y 10m
Avg Prosecution
25 currently pending
Career history
979
Total Applications
across all art units

Statute-Specific Performance

§101
0.8%
-39.2% vs TC avg
§103
58.1%
+18.1% vs TC avg
§102
11.8%
-28.2% vs TC avg
§112
20.3%
-19.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 954 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group I, claims 1-9 in the reply filed on 4/10/25 is acknowledged. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-9 are rejected under 35 U.S.C. 103 as being unpatentable over Molinier et al (US10781149). Molinier teaches a transalkylation process. Molinier, claim 12, teaches the transalkylation catalyst comprises a first molecular sieve in a first catalyst bed and a second molecular sieve in a second catalyst bed; and wherein conducting the transalkylation reaction comprises: supplying the feedstream to the first molecular sieve to produce a first effluent; and supplying the first effluent to the second molecular sieve. Molinier, col. 10, teaches the first catalyst comprises at least 1 wt %, preferably at least 10 wt %, more preferably at least 50 wt %, and most preferably at least 65 wt %, of the first molecular sieve. The second catalyst comprises at least 1 wt %, preferably at least 10 wt %, more preferably at least 50 wt %, and most preferably at least 65 wt %, of the second molecular sieve. Molinier, col. 12, teaches the first catalyst comprises 0.01 to 5 wt %, preferably 0.1 to 2 wt %, more preferably 0.1 to 1 wt %, of a first metal element of Groups 6-10. The second catalyst comprises 0 to 5 wt %, preferably 0.01 to 2 wt %, more preferably 0.01 to 1 wt %, of a second metal element of Groups 6-10. The first metal element and the second metal element may be at least one hydrogenation component, such as tungsten, vanadium, molybdenum, rhenium, chromium, manganese, a metal selected from Groups 6-10 of the Periodic Table of the Elements, or mixtures thereof. The amount of the hydrogenation component is selected according to a balance between hydrogenation activity and catalytic functionality. Less of the hydrogenation component is required when the most active metals such as platinum are used as compared to palladium, which does not possess such strong hydrogenation activity. It would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains to choose the amount of the hydrogenation component in both the first catalyst bed and second catalyst bed to obtain a specific balance between hydrogenation activity and catalytic functionality in each bed. Regarding claim 2, Molinier, col. 16, teaches the process further comprises a step of contacting the paraffinic compounds in the C9+A feedstock and/or the C6A/C7A feedstock with a third catalyst comprising a third molecular sieve having a Constraint Index in the range of 3-12 under first cracking conditions sufficient to crack at least 50 wt % of the paraffinic compounds. It would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains to choose the amount of the hydrogenation component in third catalyst bed to obtain a specific balance between hydrogenation activity and catalytic functionality in each bed. Regarding claims 3-4, Molinier, col. 12, teaches Mo. Regarding claims 5-6, Molinier, col. 10, teaches the catalyst system has a weight ratio of the first catalyst over the second catalyst in the range of 5:95 to 75:25. Regarding claim 7, Molinier, col. 10, teaches ZSM-5 which is an MFI zeolite. Regarding claim 8, Molinier, col. 12, teaches each molecular sieve can be composited with a porous matrix binder material. Regarding claim 9, Molinier, col. 12, teaches the second catalyst comprises 0 to 5 wt % of a second metal element of Groups 6-10. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. US8481443 teaches transalkylation of heavy aromatic hydrocarbon feedstocks. Any inquiry concerning this communication or earlier communications from the examiner should be directed to STEFANIE J COHEN whose telephone number is (571)270-5836. The examiner can normally be reached 10am- 6pm M-F. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Coris Fung can be reached at (571) 270-5713. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /STEFANIE J COHEN/Examiner, Art Unit 1732 3/2/26
Read full office action

Prosecution Timeline

Sep 12, 2023
Application Filed
Mar 02, 2026
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12600841
Biodegradable Composition and Method of Preparation Thereof
2y 5m to grant Granted Apr 14, 2026
Patent 12595411
Series of Alkali Metal Borophosphates Compounds, and Alkali Metal Borophosphates Nonlinear Optical Crystals as well as Preparation Method and Application thereof
2y 5m to grant Granted Apr 07, 2026
Patent 12595179
SYNTHESIS OF UNIFORM DIAMOND NANOPARTICLES
2y 5m to grant Granted Apr 07, 2026
Patent 12590205
HIGHLY SOLUBLE PEA STARCH AS REPLACER OF MALTODEXTRIN
2y 5m to grant Granted Mar 31, 2026
Patent 12590008
PROCESS FOR PRODUCING HIGH PURITY ALUMINIUM MATERIALS
2y 5m to grant Granted Mar 31, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
75%
Grant Probability
78%
With Interview (+2.7%)
2y 10m
Median Time to Grant
Low
PTA Risk
Based on 954 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month